Macatangay BJ, Zheng L, Rinaldo CR, Landay AL, Pollard RB, Pahwa S, Lederman MM, Bucy RP. 2010. Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181. Clin Vaccine Immunol. 17(9):1452-9. PMID: 20631337
Twigg HL, Schnizlein-Bick CT, Weiden M, Valentine F, Wheat J, Day RB, Rominger H, Zheng L, Collman RG, Coombs RW, Bucy RP, Rezk NL, Kashuba AD. 2010. Measurement of antiretroviral drugs in the lungs of HIV-infected patients. HIV Ther. 4(2):247-251. PMID: 20436781
Tanriver Y, Ratnasothy K, Bucy RP, Lombardi G, Lechler R. 2010. Targeting MHC class I monomers to dendritic cells inhibits the indirect pathway of allorecognition and the production of IgG alloantibodies leading to long-term allograft survival. J Immunol. 184(4):1757-64. PMID: 20083658
Gandhi RT, O'Neill D, Bosch RJ, Chan ES, Bucy RP, Shopis J, Baglyos L, Adams E, Fox L, Purdue L, Marshak A, Flynn T, Masih R, Schock B, Mildvan D, Schlesinger SJ, Marovich MA, Bhardwaj N, Jacobson JM; AIDS Clinical Trials Group A5130 team. 2009. A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy. Vaccine. 27(43):6088-94. PMID: 19450647
Brennan TV, Jaigirdar A, Hoang V, Hayden T, Liu FC, Zaid H, Chang CK, Bucy RP, Tang Q, Kang SM. 2009. Preferential priming of alloreactive T cells with indirect reactivity. Am J Transplant. 9(4):709-18. PMID: 19344462
Tsang JY, Tanriver Y, Jiang S, Xue SA, Ratnasothy K, Chen D, Stauss HJ, Bucy RP, Lombardi G, Lechler R. 2008. Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J Clin Invest. 118(11):3619-28. PMID: 18846251
Kapp JA, Bucy RP. 2008. CD8+ suppressor T cells resurrected. Hum Immunol. 69(11):715-20. PMID: 18817830.
Tsang, J. Y., Tanriver, Y., Jiang, S., Xue, S. A., Ratnasothy, K., Chen, D., Stauss, H. J., Bucy, R. P., Lombardi, G., and Lechler, R. 2008. Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J Clin.Invest. 118:3619-3628 PMID: 18846251
Twigg, H. L., Weiden, M., Valentine, F., Schnizlein-Bick, C. T., Bassett, R., Zheng, L., Wheat, J., Day, R. B., Rominger, H., Collman, R. G., Fox, L., Brizz, B., Dragavon, J., Coombs, R. W., and Bucy, R. P. 2008. Effect of Highly Active Antiretroviral Therapy on Viral Burden in the Lungs of HIV-Infected Subjects. J.Infect.Dis. 197:109-116 PMID: 18171293
Mitsuyasu, R., Gelman, R., Cherng, D. W., Landay, A., Fahey, J., Reichman, R., Erice, A., Bucy, R. P., Kilby, J. M., Lederman, M. M., Hamilton, C. D., Lertora, J., White, B. L., Tebas, P., Duliege, A. M., and Pollard, R. B. 2007. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328. Arch.Intern.Med. 167:597-605 PMID: 17389292
Kilby JM, Bucy RP, Mildvan D, Fischl M, Santana-Bagur J, Lennox J, Pilcher C, Zolopa A, Lawrence J, Pollard RB, Habib RE, Sahner D, Fox L, Aga E, Bosch RJ, Mitsuyasu R; Adult AIDS Clinical Trials Group A5024 Protocol Team. 2006. A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024). J Infect Dis. 194(12):1672-6. PMID: 17109338.
Kapp JA, Honjo K, Kapp LM, Xu X, Cozier A, Bucy RP. 2006. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection. Int Immunol. 18(11):1549-62. PMID: 16966495.
J. M. Jacobson, R. P. Bucy, J. Spritzler, M. S. Saag, J. J. Eron, R.W. Coombs, R. Wang L. Fox, S.Cu-Uvin, S. E. Cohn, D. Mildvan, D. O’Neill, J. Janik, D.K. O’Connor, C. Di Vita, I. Frank. 2006. Evidence that Intermittent Structured Treatment Interruption (STI), But Not Immunization with ALVAC-HIV vCP1452, Promotes Host Control of HIV Replication: The Results of ACTG 5068 J. Infect. Dis. 194:623-632 PMID: 16897661.
Bates JT, Bucy RP. 2005. Enhanced responsiveness to antigen contributes more to immunological memory in CD4 T cells than increases in the number of cells. Immunology. 116(3):318-27.PMID: 16236121
Bucy RP. 2004. Viral and cellular dynamics in HIV disease. Curr HIV/AIDS Rep. 1(1):40-6. . PMID: 16091222.
Triozzi PL, Strong TV, Bucy RP, Allen KO, Carlisle RR, Moore SE, Lobuglio AF, Conry RM. 2005. Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma. Hum Gene Ther. 16(1):91-100. PMID: 15703492.
Honjo K, Xu XY, Kapp JA, Bucy RP. 2004. Activation and migration of allo-peptide specific TCR transgenic T cells in cardiac allograft rejection. Cell Immunol. 230(1):44-55. PMID: 15541718.
Honjo K, Yan Xu X, Kapp JA, Bucy RP. 2004. Evidence for cooperativity in the rejection of cardiac grafts mediated by CD4 TCR Tg T cells specific for a defined allopeptide. Am J Transplant. 4(11):1762-8. PMID: 15476474.
Honjo K, Xu X, Bucy RP. 2004. CD4+ T-cell receptor transgenic T cells alone can reject vascularized heart transplants through the indirect pathway of alloantigen recognition. Transplantation. 77(3):452-5. PMID: 14966425.